ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm Receives $8.2m R&D Tax Incentive Refund
Published: 07/06/22, 08:23am (AEST)•1 pages